SLS 3Q18 results—pro forma cash=$16.6M (including $6.6M litigation settlement received a few days ago): https://globenewswire.com/news-release/2018/11/15/1652143/0/en/SELLAS-Life-Sciences-Provides-Business-Update-and-Reports-Third-Quarter-2018-Financial-Results.html CFO says cash is sufficient for operating expenses through 3/31/19, which is pretty soon, LOL.